Xia Yuanqing, Zhong Lumin, Tan Jingcong, Zhang Zhiruo, Lyu Jiajun, Chen Yiting, Zhao Anda, Huang Lili, Long Zichong, Liu Ning-Ning, Wang Hui, Li Shenghui
School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
International Peace Maternity & Child Health Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Front Cell Dev Biol. 2020 Sep 24;8:547314. doi: 10.3389/fcell.2020.547314. eCollection 2020.
The COVID-19 pandemic has been a global threat. Through rapid and effective surveillance and control, the newly confirmed patients have been fluctuated at a very low level and imported case explained most of them through March, 2020 to the present, indicating China's response has achieved a stage victory. By contrast, the epidemic of COVID-19 in other countries out of China is bursting. Different countries are adopting varied response strategy in terms of their public health system to prevent the spread. Herd immunity has been a hot topic since the outbreak of COVID-19 pandemic. Can it be a possible strategy to combat COVID-19? To fully interpret the knowledge regarding the term upon the background of COVID-19-related health crisis, we aim to systematically review the definition, describe the effective measures of acquiring herd immunity, and discuss its feasibility in COVID-19 prevention. Findings from this review would promote and strengthen the international cooperation and joint efforts when confronting with COVID-19.
新冠疫情一直是全球威胁。通过快速有效的监测和防控，新确诊患者数量在非常低的水平波动，2020年3月至今，输入病例占大多数，这表明中国的应对取得了阶段性胜利。相比之下，中国以外其他国家的新冠疫情正在爆发。不同国家根据其公共卫生系统采取了不同的应对策略来防止传播。自新冠疫情爆发以来，群体免疫一直是热门话题。它能否成为对抗新冠疫情的一种可能策略？为了在新冠疫情相关的健康危机背景下全面解读这个术语的相关知识，我们旨在系统回顾其定义，描述获得群体免疫的有效措施，并讨论其在预防新冠疫情中的可行性。本综述的研究结果将促进和加强应对新冠疫情时的国际合作与共同努力。
